SOAT1 and lymphoma: Studies have shown that excessive activation of the JAK/STAT pathway has been detected in several solid cancers (lung, breast, head, and neck) and hematologic malignancies (multiple myeloma, lymphoma, and non-lymphoma), as well as in acute leukemia [101].